# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.05) by 2...
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...
Iridex Corporation (NASDAQ:IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery d...
Iridex Corporation, headquartered in Mountain View, California, and Imperial College Healthcare NHS Trust in London, today anno...